antihemophilic factor (recombinant), a sterile, purified, coagulation factor VIII concentrate produced by recombinant technology that possesses biological activity comparable with that of human plasma-derived coagulation factor VIII. It is used to prevent or stop hemorrhage during surgery or other procedures in patients with hemophilia A. It is administered intravenously.
